Advertisement
Review Article| Volume 135, ISSUE 2, e25-e31, February 2023

Cervicofacial hidradenitis suppurativa: A case report and literature review

      Hidradenitis suppurativa (HS) is a chronic inflammatory condition of the apocrine glands primarily affecting the axillae, perineum, and inframammary regions. It is characterized by painful, inflamed cutaneous lesions causing nodules, sinus tracts, and abscesses. Cervicofacial HS is an atypical presentation of HS in the head and neck region and is scarcely reported in the literature. We present a 34-year-old male who developed a large facial swelling overlying the left inferior mandibular border. Management included surgical incision and drainage, antibiotic therapy, followed by infliximab (Remicade). The purpose of this case report was to highlight the presentation, pathophysiology, interdisciplinary approach to treatment and follow-up of patients with cervicofacial HS, and finally, review the cervicofacial HS literature.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Jemec GB.
        Clinical practice. Hidradenitis suppurativa.
        N Engl J Med. 2012; 366: 158-164
        • Jfri A
        • Nassim D
        • O'Brien E
        • Gulliver W
        • Nikolakis G
        • Zouboulis CC.
        Prevalence of hidradenitis suppurativa: a systematic review and meta-regression analysis.
        JAMA Dermatol. 2021; 157: 924-931
        • Lapins J
        • Jarstrand C
        • Emtestam L.
        Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery.
        Br J Dermatol. 1999; 140: 90-95
        • Fitzsimmons JS
        • Guilbert PR.
        A family study of hidradenitis suppurativa.
        J Med Genet. 1985; 22: 367-373
        • Wang B
        • Yang W
        • Wen W
        • et al.
        Gamma-secretase gene mutations in familial acne inversa.
        Science. 2010; 330: 1065
        • Ingram JR.
        The Genetics of hidradenitis suppurativa.
        Dermatol Clin. 2016; 34: 23-28
        • Alikhan A
        • Lynch PJ
        • Eisen DB.
        Hidradenitis suppurativa: a comprehensive review.
        J Am Acad Dermatol. 2009; 60: 539-561
        • König A
        • Lehmann C
        • Rompel R
        • Happle R.
        Cigarette smoking as a triggering factor of hidradenitis suppurativa.
        Dermatology. 1999; 198: 261-264
        • Tchero H
        • Herlin C
        • Bekara F
        • Fluieraru S
        • Teot L.
        Hidradenitis suppurativa: a systematic review and meta-analysis of therapeutic interventions [published correction appears in Indian J Dermatol Venereol Leprol. 2019;85:617].
        Indian J Dermatol Venereol Leprol. 2019; 85: 248-257
        • Esmann S
        • Jemec GB.
        Psychosocial impact of hidradenitis suppurativa: a qualitative study.
        Acta Derm Venereol. 2011; 91: 328-332
        • Wolkenstein P
        • Loundou A
        • Barrau K
        • Auquier P
        • Revuz J.
        Quality of life impairment in hidradenitis suppurativa: a study of 61 cases.
        J Am Acad Dermatol. 2007; 56: 621-623
        • Jemec GB
        • Faber M
        • Gutschik E
        • Wendelboe P.
        The bacteriology of hidradenitis suppurativa.
        Dermatology. 1996; 193: 203-206
        • Wieczorek M
        • Walecka I.
        Hidradenitis suppurativa - known and unknown disease.
        Reumatologia. 2018; 56: 337-339
        • Horváth B
        • Janse IC
        • Blok JL
        • Driessen RJ
        • Boer J
        • Mekkes JR
        • Prens EP
        • van der Zee HH
        Hurley staging refined: a proposal by the Dutch hidradenitis suppurativa expert group.
        Acta Derm Venereol. 2017; 97: 412-413
        • Saunte DML
        • Jemec GBE.
        Hidradenitis suppurativa: advances in diagnosis and treatment.
        JAMA. 2017; 318: 2019-2032
        • Mendonça CO
        • Griffiths CEM.
        Clindamycin and rifampicin combination therapy for hidradenitis suppurativa.
        Br J Dermatol. 2006; 154: 977-978
        • Bettoli V
        • Zauli S
        • Borghi A
        • et al.
        Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients.
        J Eur Acad Dermatol Venereol. 2014; 28: 125-126
        • Clemmensen OJ.
        Topical treatment of hidradenitis suppurativa with clindamycin.
        Int J Dermatol. 1983; 22: 325-328
        • Jemec GB
        • Wendelboe P.
        Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa.
        J Am Acad Dermatol. 1998; 39: 971-974
        • Dessinioti C
        • Zisimou C
        • Tzanetakou V
        • Stratigos A
        • Antoniou C.
        Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up.
        Clin Exp Dermatol. 2016; 41: 852-857
        • Mehdizadeh A
        • Hazen PG
        • Bechara FG
        • et al.
        Recurrence of hidradenitis suppurativa after surgical management: a systematic review and meta-analysis.
        J Am Acad Dermatol. 2015; 73: S70-S77
        • Janse I
        • Bieniek A
        • Horváth B
        • Matusiak Ł.
        Surgical procedures in hidradenitis suppurativa.
        Dermatol Clin. 2016; 34: 97-109
        • Doménech C
        • Matarredona J
        • Escribano-Stablé JC
        • Devesa JP
        • Vicente J
        • Jaén A.
        Facial hidradenitis suppurativa in a 28-year-old male responding to finasteride.
        Dermatology. 2012; 224: 307-308
        • Greer KE.
        Letter: facial involvement with hidradenitis suppurativa.
        Arch Dermatol. 1974; 109: 408
        • Castrillón Velásquez MA
        • Kim M
        • Tan MH
        • Tran K
        • Murrell DF
        an atypical localized form of hidradenitis suppurativa of the jawline and neck mimicking severe cystic acne on presentation.
        Skin Appendage Disord. 2017; 3: 215-218
        • Poli F
        • Wolkenstein P
        • Revuz J.
        Back and face involvement in hidradenitis suppurativa.
        Dermatology. 2010; 221: 137-141
        • Scherman AJ.
        Nodulocystic acne and hidradenitis suppurativa treated with acitretin: a case report.
        Cutis. 2002; 69: 287-288